Country Industry Forecast-Political and Policy Analysis for the Japanese Healthcare Industry

Country Industry Forecast-Political and Policy Analysis for the Japanese Healthcare Industry

 

RELEASE DATE
15-Jul-2008
REGION
Asia Pacific
Research Code: 4H72-01-00-00-00
SKU: HC00177-AP-DE_03088

$450.00

Special Price $337.50 save 25 %

In stock
SKU
HC00177-AP-DE_03088

$450.00

$337.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The Japanese healthcare industry is the second largest in the world after the United States, and account for 10.0 percent of the world’s market. The success of this industry has been mainly due to the Japanese Government’s supportive role through favorable polices and funds.The Japanese drug market is opening up for foreign investors with the separation of marketing from manufacturing and an improvement in the drug approval system. The revision of the Pharmaceutical Affair Law has made it easier for foreign nationals to operate in the country.This Country Industry Forecast study provides an in-depth analysis of political and policy issues and their implications and key growth opportunities for the Japanese Healthcare Industry.

Table of Contents

Industry Overview and Healthcare System

  • Overview of Healthcare Industry and Healthcare System

Pharmaceutical Segment

  • Overview of Pharmaceutical Segment

Biotechnology Segment

  • Overview of Biotechnology Segment

Clinical Trials Segment

  • Overview of Clinical Trial Segment

Medical Devices and Equipment Segment

  • Overview of Medical Devices and Equipment Segment

Healthcare IT Segment

  • Overview of Healthcare IT Segment
Related Research
The Japanese healthcare industry is the second largest in the world after the United States, and account for 10.0 percent of the worlds market. The success of this industry has been mainly due to the Japanese Governments supportive role through favorable polices and funds.The Japanese drug market is opening up for foreign investors with the separation of marketing from manufacturing and an improvement in the drug approval system. The revision of the Pharmaceutical Affair Law has made it easier for foreign nationals to operate in the country.This Country Industry Forecast study provides an in-depth analysis of political and policy issues and their implications and key growth opportunities for the Japanese Healthcare Industry.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 4H72-01-00-00-00
Is Prebook No